MedTrace Logo

Vocal Feature Analysis Algorithm for COVID-19 Detection

NCT04418544 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-10-30

No results posted yet for this study

Summary

This is an observational, prospective, non-randomized, non-significant risk study collecting voice recordings from subjects who are being tested for COVID-19 by laboratory analysis of specimens obtained by nasal or naso-pharyngeal (NP) swab. Patients record their voices through an app on their mobile phone. Patients and health care providers will be blinded to the swab test results during Phase 2 of the study.

Conditions

Interventions

DEVICE

Device used to record voice for screening

voice recording

Sponsors & Collaborators

  • UserWise, LLC

    collaborator INDUSTRY

  • Soniphi LLC

    lead INDUSTRY

Principal Investigators

  • Stephen Steady, MD · Soniphi LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-12-31
Completion
2020-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04418544 on ClinicalTrials.gov